Anti-ORF7a [3C9]

Monoclonal antibody used to study the role of ORF7a within SARS coronavirus.

Contributors

Institute
A*STAR Accelerate Technologies Pte Ltd
Cat. #: 152647
Unit size: 100 ug
Research Fields: Cell signaling and signal transduction;Neurobiology
Application: IF ; WB
Target: SARS CoV ORF7a (also known as U122)
Reactivity: Virus
Clone: 3C9
Host: Mouse
Class: Monoclonal
Product description: Monoclonal antibody used to study the role of ORF7a within SARS coronavirus. Background and Research Application A novel coronavirus (termed as SARS-CoV) has been identified as the etiological agent of severe acute respiratory syndrome (SARS). The SARS-CoV genome encodes the essential CoV replication and structural proteins. In addition, the genome encodes eight 8 putative accessory proteins (i.e. ORFs 3a, 3b, 6, 7a, 7b, 8a, 8b and 9b) that do not show significant homology to viral proteins of known coronaviruses, i.e. they are unique to SARS-CoV. It is known to infect humans, bats and various other mammals. ORF7a, also known as U122, consists of 122 amino acids and is localized mainly in ER-Golgi intermediate compartment, where coronaviruses are known to assemble and bud. ORF7a can also be incorporated into the virion. The over-expression of ORF7a induces apoptosis and block cell cycle progression at G0/G1 phase. This is via interfering with pro-survival proteins such as Bcl-XL, Bcl-w, Mcl-1, and A1.
Conjugation: Unconjugated
Isotype: IgG1
Molecular weight: 14 kDa
Immunogen: GST-7a (16-111 amino acids)
Immunogen Uniprot ID: J9T5H6
Myeloma used: Sp2/0-Ag14
Target background: Monoclonal antibody used to study the role of ORF7a within SARS coronavirus. Background and Research Application A novel coronavirus (termed as SARS-CoV) has been identified as the etiological agent of severe acute respiratory syndrome (SARS). The SARS-CoV genome encodes the essential CoV replication and structural proteins. In addition, the genome encodes eight 8 putative accessory proteins (i.e. ORFs 3a, 3b, 6, 7a, 7b, 8a, 8b and 9b) that do not show significant homology to viral proteins of known coronaviruses, i.e. they are unique to SARS-CoV. It is known to infect humans, bats and various other mammals. ORF7a, also known as U122, consists of 122 amino acids and is localized mainly in ER-Golgi intermediate compartment, where coronaviruses are known to assemble and bud. ORF7a can also be incorporated into the virion. The over-expression of ORF7a induces apoptosis and block cell cycle progression at G0/G1 phase. This is via interfering with pro-survival proteins such as Bcl-XL, Bcl-w, Mcl-1, and A1.
Format: Liquid
Shipping conditions: Dry ice
References:

Tan et al. 2007. J Virol. 81(12):6346-55. PMID: 17428862.

Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein.

Related Tools for Antibodies

Cat. # Tool Name
151023 Anti-IL12 [1-1D5] Key Info View Tool
151025 Anti-Vascular endothelium [10] Key Info View Tool
151026 Anti-FCGR1 [10.1] mAb Key Info View Tool
151035 Anti-CD8 [14] mAb Key Info View Tool
151037 Anti-Cdk1 [17 (A17)] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.